Shanghai MicroPort Endovascular MedTech Co., Ltd (SHA: 688016) has received marketing approval from the National Medical Products Administration (NMPA) for its fiber wool plug spring coil, a device used for the filling treatment of peripheral vascular aneurysms, arteriovenous malformations, and arteriovenous fistulas.
The spring coil is constructed from a platinum tungsten alloy spring coil body and dense fiber hair, offering excellent imaging capabilities, MRI compatibility, and biocompatibility. Available in a range of diameters and lengths, it is the most versatile free spring coil in China, designed to meet the clinical needs for coil embolization surgeries.
Endovascular MedTech now has a total of six peripheral arterial products approved for marketing in China, with this product marking its first approved embolic offering. – Flcube.com
